Insider Selling: Castle Biosciences, Inc. (NASDAQ:CSTL) Director Sells 9,152 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.45, for a total value of $196,310.40. Following the completion of the sale, the director now directly owns 22,782 shares of […]

Related Keywords

United States ,American ,Castle Biosciences ,Daniel Bradbury ,Securities Exchange Commission ,First Republic Investment Management Inc ,Baird Financial Group Inc ,Keycorp ,Castle Biosciences Company Profile ,Tower Research Capital ,Pricet Rowe Associates Inc ,American International Group Inc ,Castle Biosciences Inc ,Nasdaq ,Scotiabank ,Get Free Report ,Director Daniel Bradbury ,Exchange Commission ,International Group ,Republic Investment Management ,Financial Group ,Research Capital ,Mypath Melanoma ,Castle Biosciences Daily ,Nasdaq Cstl ,Cstl ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,